How Nurses Become Clinical Advisors to Medtech Companies

If you are a registered nurse in the UK and you have been quietly wondering whether medtech companies would pay for your clinical expertise, the answer is yes. They already do, they need more of you, and most of them have no idea how to find you. This post walks through how nurses actually become clinical advisors to medtech companies, what the NMC lets you do, what founders will pay for, and how to land your first contract this quarter.

What "clinical advisor" actually means when a medtech company hires a nurse

A clinical advisor is a registered healthcare professional who is paid, in cash or equity or both, to shape how a product gets built, evaluated, or adopted. For nurses, that work usually sits in three places: workflow design, safety, and NHS adoption. Companies do not want a generic clinician. They want someone who has, this month, physically used a similar product on a real patient.

Nurses are underused in this market for a bad reason and a good reason. The bad reason is that founders default to hiring consultants and doctors because those names look impressive on a slide. The good reason is that nurses are harder to reach: you are not on speaker circuits, you are not writing on LinkedIn, and your registration body does not maintain a public "available for consultancy" flag. That gap is your opportunity.

The work itself is usually one of five things. Design reviews of a product or workflow. Structured feedback sessions on a prototype. Sitting on a clinical advisory board with quarterly meetings. Being named on a regulatory submission as the clinical expert. Or acting as a bridge into an NHS trust for a pilot.

The insight most nurses miss: your NHS scope is your product-market fit

Here is the thing founders will not tell you, mostly because they do not know how to phrase it. The single most valuable thing about you as a nurse advisor is not your clinical opinion. It is the fact that you know, in operational detail, what an actual shift looks like on your ward, on your community round, in your ED, or in your specialist clinic.

Medtech products fail in the last three feet. A device works in bench testing, passes clinical evaluation, gets a CE mark or UKCA, and then does not get used because it adds four seconds to a handover, or because the charger cable cannot reach the bay, or because it needs a login the bank staff do not have. That is the layer where nurses win. If you can tell a founder, with specifics, why their beautiful product will die at 07:15 on a Monday, you have earned your day rate.

This reframes how you should present yourself. Not "I am a nurse with X years of experience". Instead: "I am a Band 6 in acute stroke, I lead the thrombolysis pathway at Trust Y, and I can tell you exactly why your bedside tool will or will not survive contact with our floor." Specificity is what gets you hired.

The NMC rules that actually matter

You can do paid work outside the NHS. The NMC Code does not prohibit it. What it does require is that you act with integrity, avoid conflicts of interest, and remain accountable for your practice. Read the Code once, and pay particular attention to sections 20 and 21 on upholding the profession and being open and honest.

Three practical rules follow from that. First, declare it. Your NHS employer will almost always have a "declaration of interests" or "secondary employment" process, and you should use it before you sign an advisor agreement, not after. Second, ring-fence the time. You cannot advise a medtech company on their bedside device while you are on shift being paid to use bedside devices. Third, be careful with patient information. You can describe your general clinical experience. You cannot share identifiable case details, and you should not photograph or record any clinical environment for a company's benefit without formal ethical approval.

Revalidation is the other piece. Advisory work can count towards your practice hours if it involves your professional knowledge and skills, but this is not automatic. Keep contemporaneous notes of what you did and how it drew on your registered practice, and get written reflective accounts signed off in your normal way. Do not assume "I was a paid advisor" is enough on its own.

A quick reality check. If your NHS contract has a specific clause on external work (many senior nursing and midwifery contracts do, especially in specialist areas or where you hold a lead role), read it. The NMC does not override your employment contract. Getting fired from your day job to earn £2,000 as an advisor is not a good trade.

Day rates and equity: what UK nurses are actually getting in 2026

Rates vary enormously by specialty, seniority, and how commercially useful you are, but a rough map helps. For a Band 6 or 7 nurse with a relevant specialist background, day rates in the UK healthtech market in 2026 typically sit between £600 and £1,200. Senior nurses (Band 8a and above), clinical nurse specialists in high-demand areas like oncology, cardiology, mental health, or advanced practice, will often clear £1,500 a day. Nurse consultants with published work or NICE committee experience can go higher again.

Advisor equity for a named seat on a clinical advisory board typically sits in the 0.2% to 1% range, vesting over two to four years with a one-year cliff. Do not accept equity in place of cash unless you genuinely believe in the company and can afford to have the shares be worth zero, because in medtech many of them will be. A hybrid deal (a modest day rate plus equity) is the healthy default.

Two things push your rate up faster than time on the register. One is being able to open doors into your trust for a pilot or evaluation, which is genuinely rare and genuinely valuable. The other is being named on regulatory documentation, because that carries personal accountability and companies price it accordingly. See our case studies for how experts have structured deals across both models.

Three real examples

Startup example. A UK maternity monitoring startup was building a wearable for early detection of pre-eclampsia. Their first hire off Orbion was not an obstetrician. It was a Band 7 midwife who led triage in a busy MFAU (maternal foetal assessment unit). She spent two afternoons per month with the product team for six months. Her single most valuable contribution was rewriting the alert thresholds so that midwives received one meaningful escalation per shift instead of eleven. The company kept its ISO 13485 auditor happy, cut their false-positive rate by two-thirds, and paid her £950 a day plus 0.35% equity.

NHS example. An NHS trust in the North West was running a procurement evaluation for three competing electronic observations platforms. The trust's digital nursing lead was formally seconded, one day a week for three months, to co-design the evaluation criteria with the winning vendor before rollout. The commercial arrangement was declared through the trust's conflicts register, the vendor paid the trust (not the individual), and the nurse's regular pay continued. This is the "seconded advisor" model, and it is becoming more common as trusts get more sophisticated about IP and time.

Failure example. A community nurse signed a two-year advisor agreement with a wound care startup for 0.5% equity and no cash. She was told she would be "on call" for informal design questions. Six months in, the founder was calling her three evenings a week for two-hour product review sessions, most of them low-signal. She had not negotiated a scope of work, a monthly hour cap, or an exit clause. She could not walk away without losing the shares she had already vested, and she could not raise it commercially because she had never invoiced. The failure was not the equity. It was the missing paperwork.

Common mistakes nurses make in their first advisory role

The first mistake is under-pricing yourself. The company has budgeted for a clinical advisor. If you quote £400 a day, you will get £400 a day, and the founder will privately downgrade how seriously they take you. Quote your real rate, calmly, with a one-line justification, and let them negotiate down if they must.

The second is doing unpaid "trial" work. Founders will ask for a "quick call to sense-check something" and then a "quick review of these five documents". This is billable work. Say so from the first call. A five-line email confirming rate, scope, and payment terms before you write anything is enough.

The third is failing to declare. If your employer finds out you have been advising a medtech company through a routine audit rather than through your own declaration, you are in a much worse position than if you had raised it upfront. The declaration protects you, not them.

How to land your first contract this quarter

Write a one-page profile that leads with your specialty, your setting, and one specific operational thing you know that a founder would pay to learn. A profile reads differently from a CV: it is shorter, it is oriented around what the founder needs, and it makes the ask explicit. Get it in front of medtech companies working in your clinical area, either directly through their websites, through their clinical leads on LinkedIn, or through an expert marketplace built for this like Orbion Connect.

Then do something most nurses do not do: name your rate in your first reply. Founders are used to negotiating with lawyers, consultants, and doctors, all of whom quote a number in the opening exchange. When you do not, they read it as inexperience. When you do, they read it as a professional.

The UK medtech market is short of experienced nurse advisors, and the companies that will win in the next five years know it. Your NMC registration, your clinical specialty, and your operational knowledge of NHS delivery are worth real money. Get paid for them.